Agglutination of Human Polyomaviruses by Using a Tetravalent Glycocluster as a Cross-Linker
Agglutination of Human Polyomaviruses by Using a Tetravalent Glycocluster as a Cross-Linker
复制标题
DOI:
10.1021/acsomega.0c03269
复制
发表时间:
2020-09-01
期刊:
影响因子:
4.1
通讯作者:
Suzuki, Tetsuro
中科院分区:
文献类型:
--
作者:
Ogata, Makoto;Onoda, Takashi;Suzuki, Tetsuro
Two kinds of tetravalent double-headed sialo-glycosides with short/long spacers between the Neu5Ac alpha 2,6Gal beta 1,4GlcNAc unit and ethylene glycol tetraacetic acid (EGTA) scaffold were found to be capable of binding to virus-like particles of Merkel cell polyomavirus (MCPyV-LP). The binding process and time course of interaction between the tetravalent ligand and MCPyV-LP were assessed by dynamic light scattering (DLS). On the addition of increasing concentrations of ligand to MCPyV-LP, larger cross-linked aggregates formed until a maximum size was reached. The binding was stronger for the tetravalent ligand with a short spacer than for that with a long spacer. The binding of the former ligand to the virus was observed to proceed in two stages during agglutination. The first step was the spontaneous formation of small aggregates comprising the crosslinked ligand-virus complex. In the second step, the aggregates grew successively larger by cooperative binding among the initially produced small aggregates. In transmission electron microscopy, the resulting complex was observed to form aggregates in which the ligands were closely packed with the virus particles. The cross-linked interaction was further confirmed by a simple membrane filtration assay in which the virus-like particles were retained on the membrane when complexed with a ligand. The assay also showed the effective capture of particles of pathogenic, infectious human polyomavirus JCPyV when complexed with a ligand, suggesting its possible application as a method for trapping viruses by filtration under conditions of virus aggregation. Collectively, these results show that the tetravalent glycocluster serves as a ligand not only for agglutinating MCPyV-LP but also for trapping the pathogenic virus.